Schreiner MediPharm celebrates first US facility

Schreiner MediPharm, a Germany-based provider of specialty pharmaceutical labels for over 50 years, recently celebrated the grand opening of its first US production facility, Schreiner MediPharm, L.P., 30 miles from New York City, in Blauvelt, New York. About 100 customers, suppliers, employees, local politicians and national trade media attended the event, which was a combination open house/Oktoberfest celebration.

The event began with opening speeches from Roland Schreiner, global president of Schreiner MediPharm, and Gene Dul, the president of Schreiner MediPharm, L.P. in the US.

‘This company began in my grandparents’ basement in 1951 and has developed into a global $145 million enterprise with more than 650 employees. It was a very big step for us to open a production facility in the US, in a new country with a different language and culture, ’Roland Schreiner said. ‘But we are very happy that we made this important move. Thus we are demonstrating our commitment to be here, where so much of the pharmaceutical industry is based. We can now provide our manufacturing expertise, labeling innovations and support to our North American customers directly from an American location.’

A ribbon-cutting with local officials followed, as well as a plant tour of Schreiner MediPharm’s 50,000 sq ft facility featuring a variety of fully validated screen and flexo printing technologies designed to meet the pharmaceutical industry’s most demanding labeling challenges.

In addition to Schreiner, several top executives from Schreiner MediPharm’s global headquarters in Munichwere on hand for the event.